Highly variable SARS-CoV-2 spike antibody responses to two doses of COVID-19 RNA vaccination in patients with multiple myeloma
Oliver Van Oekelen(Icahn School of Medicine at Mount Sinai), Samir Parekh(Icahn School of Medicine at Mount Sinai), Maria C. Bermúdez‐González(Icahn School of Medicine at Mount Sinai), Rao Mendu, Ashley-Beathrese T. Salimbangon(Icahn School of Medicine at Mount Sinai), Sundar Jagannath(Mount Sinai Hospital), Daniel Floda(Icahn School of Medicine at Mount Sinai), Sarita Agte(Northwestern University), Emily D. Ferreri(Icahn School of Medicine at Mount Sinai), Kayla T. Russo(Icahn School of Medicine at Mount Sinai), Miti Saksena(Icahn School of Medicine at Mount Sinai), Ania Wajnberg(Icahn School of Medicine at Mount Sinai), Tarek H. Mouhieddine(Icahn School of Medicine at Mount Sinai), Katherine F. Beach(Icahn School of Medicine at Mount Sinai), Charles Gleason(Icahn School of Medicine at Mount Sinai), Komal Srivastava(Icahn School of Medicine at Mount Sinai), Rachel Chernet(SUNY Upstate Medical University), Giulio Kleiner(Icahn School of Medicine at Mount Sinai), Wanni A. Mendez(Icahn School of Medicine at Mount Sinai), Julia C. Matthews(Icahn School of Medicine at Mount Sinai), Adolfo Firpo‐Betancourt(Icahn School of Medicine at Mount Sinai), Levy A. Sominsky(Icahn School of Medicine at Mount Sinai), Florian Krammer(Icahn School of Medicine at Mount Sinai), Adolfo Aleman(Icahn School of Medicine at Mount Sinai), Carlos Cordon‐Cardo(Icahn School of Medicine at Mount Sinai), Katerina Kappes(Icahn School of Medicine at Mount Sinai), Lubbertus C. F. Mulder(Icahn School of Medicine at Mount Sinai), Bo Wang(Icahn School of Medicine at Mount Sinai), Viviana Simon(Icahn School of Medicine at Mount Sinai), Amber A. Shin, Radhika Banu(Icahn School of Medicine at Mount Sinai), Ajai Chari(Icahn School of Medicine at Mount Sinai)
Cited by 216
Related Papers
An inflammatory cytokine signature predicts COVID-19 severity and survival
|Nature Medicine|2020|2.7k
Anti-BCMA CAR T-Cell Therapy bb2121 in Relapsed or Refractory Multiple Myeloma
|New England Journal of Medicine|2019|1.7k
Influenza
|Nature Reviews Disease Primers|2018|1.5k
International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders
|Leukemia|2008|808
Antibody Responses in Seropositive Persons after a Single Dose of SARS-CoV-2 mRNA Vaccine
|New England Journal of Medicine|2021|803